Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
At week 72, primary endpoints showed 62.9% of people treated with 2.4 mg semaglutide achieved resolution of steatohepatitis with no worsening of liver fibrosis compared to 34.1% on placebo
284 In a phase 3 clinical trial, 284 eplontersen significantly reduced circulating TTR levels, mitigated nerve damage, and improved quality of life in ATTR-PN patients, resulting in its FDA approval in December 2023 for treating ATTR-PN
Nooms body scanner helps you track not just weight but also your body fat percentage and muscle mass
In 2023, Dexcom added 600,000 users to its base and has 2.3 million Dexcom users globally at year-end 2023
Freezing: This is a more nuanced topic
US$ 23.76
US$ 25.84
US$ 25.49
US$ 27.50
US$ 20.25
US$ 29.14
